Disclosures
Royalties received from Tornier/Stryker
Paid Consultant for Tornier/Stryker. Arthrex
Stock received from Sparta Biopharma / Statera
Board of Directors member for SECEC-ESSSE Treasurer
All relevant financial disclosures have been mitigated.
Disclosures complete: Aug 31, 2022
*Please note that Global Link resources are not part of the CME offered for the 2025 ISAKOS Congress.